GW PHARMACEUTICAL UP OVER 10% TODAY! BUT WHY?

GW Pharmaceutical (GWPH: NASDAQ) has quietly outperformed most of its fellow NASDAQ companies during 2015 and Technical420 has been recommending them the whole time. GWPH is up over 10% today and over 36% this year. The company manufactures and sells the first prescribed cannabis-based medicine in over 20 countries and its deep product pipeline will lead to incremental revenue growth for years to come.

A pharmaceutical, not marijuana, company

Many people think that GW Pharmaceutical is a marijuana company, but they are not. GWPH is a pharmaceutical company focused on developing treatments derived from cannabis. The company has an extensive product pipeline with each product in various stages of FDA testing. The company’s two main products in focus are Sativex and Epidolex.

Their Sativex product for cancer pain is in late stage 3 testing and they expect to receive data in the near future. If the drug is approved by...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
https://technical420.com/cannabis-article/gw-pharmaceutical-gwph-nasdaq-over-10-today-why